Helping engineering teams overcome integration, durability, and safety hurdles in harsh environments By Paulius Juskevicius, ...

WENZHOU, ZHEJIANG, CHINA, January 5, 2026 /EINPresswire.com/ — In the world of electrical engineering, automation, and power management, the relay is the quiet workhorse. It’s the component ...

Ticket sales for the third men’s T20I between India and New Zealand, to be played at the ACA Stadium on January 25, will go ...

Background Percutaneous coronary intervention (PCI) of small vessels is limited by an increased risk of restenosis and adverse outcome, even when drug-eluting stents (DES) are employed. In recent ...

Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Automotive Battery ...

Bristol Myers Squibb has become the latest Big Pharma to tie up a biotech pact as we reach the year’s end, tapping Harbour BioMed for a multiyear research deal. The new pact will see the companies ...